Anti-Amyloid Drugs: The Advantages Of Alzheon's ALZ-801 Over Biogen's AducanumabSeeking Alpha • 08/27/20
Biogen's Alzheimer's Drug And Other News: The Good, Bad And Ugly Of BiopharmaSeeking Alpha • 08/09/20
Biogen Soars As FDA Accepts Alzheimer's Drug For Review In 'Next Stage Of Aducanumab Saga'Benzinga • 08/07/20
Biogen's stock rallies 11% after FDA accepts application for experimental Alzheimer's drugMarket Watch • 08/07/20
FDA Accepts Biogen’s Aducanumab Biologics License Application for Alzheimer's Disease with Priority ReviewGlobeNewsWire • 08/07/20
Denali Therapeutics stock rockets into record territory after Biogen investment and collaborationMarket Watch • 08/06/20
Biogen and Denali to Collaborate on LRRK2 Program for Parkinson’s Disease and Certain TV Platform-Enabled Programs for Neurodegenerative DiseasesGlobeNewsWire • 08/06/20
Biogen to Present Data at Virtual 2020 Alzheimer’s Association International Conference Highlighting Comprehensive Approach to Alzheimer’s DiseaseGlobeNewsWire • 07/24/20
Biogen Inc. (BIIB) CEO Michel Vounatsos on Q2 2020 Results - Earnings Call TranscriptSeeking Alpha • 07/22/20